Andy Rawstron Indian Ocean Rim Laboratory Haematology Congress 2019

Andy Rawstron

Andy Rawstron is a Consultant Clinical Scientist at HMDS Leeds and visiting Professor with the Epidemiology and Cancer Statistics Group at University of York. His primary focus is the development and application of assays for the diagnosis and monitoring of B-cell disorders. He has established highly sensitive techniques for minimal residual disease (MRD) detection in CLL and myeloma that have been applied to many UK and international clinical trials, subsequently leading international efforts to standardise MRD detection for use as a trial endpoint to accelerate drug development. He has adapted MRD techniques to investigate the earliest stages in B-cell neoplasia and also to enable high-sensitivity monitoring of normal B-cell subsets for optimising B-cell depletion therapy in musculoskeletal disorders. Andy developed and leads a national award-winning service for monitoring people with chronic malignancies before and after treatment so that they can receive high quality disease management in a local setting.